Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus ropivacaine for rebound pain after brachial plexus block in upper limb fracture surgery
ChiCTR2300075083Phase 4Recruiting
- Sponsor
- Deyang People's Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and Rebound pain (3 arms), sponsored by Deyang People's Hospital. Primary endpoint: Incidence of rebound pain. Started Aug 2023; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painRebound pain
Beyond the preview
Go deeper on ChiCTR2300075083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075083.